Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms AC-1-277 |
Target |
Action inhibitors |
Mechanism CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC45H52N10O8 |
InChIKeyIPLIKDPWOGNBJJ-UHFFFAOYSA-N |
CAS Registry2349356-68-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Philadelphia positive acute lymphocytic leukaemia | Preclinical | United States | 30 Apr 2020 |